Alzheimer’s disease affects an increasing number of elderly individuals and is characterized by a progressive loss of memory, reasoning, and linguistic abilities. Despite the numerous drugs developed, none have yet succeeded in effectively halting or even slowing its progression. However, a promising avenue is emerging: programmed cell death, a natural mechanism that allows the body to eliminate damaged or dangerous cells.<\/p>\n
Several forms of cell death are involved in the development of the disease. For example, the excessive accumulation of iron in the brain, observed from the earliest stages, accelerates cognitive decline and promotes the formation of toxic plaques. Similarly, excessive inflammation, triggered by specific proteins, worsens symptoms by causing neuronal death and disrupting their communication.<\/p>\n
Autophagy, a process that allows cells to clean themselves by eliminating misfolded proteins and damaged mitochondria, also plays a key role. When this mechanism malfunctions, it contributes to the worsening of the disease. Conversely, stimulating autophagy could help reduce deposits of toxic proteins and improve cognitive functions.<\/p>\n
Other types of cell death, such as pyroptosis or necroptosis, are also linked to the progression of the disease. These processes, often triggered by inflammatory signals or metabolic imbalances, lead to the destruction of neurons and worsen memory disorders. Studies show that blocking certain proteins involved in these mechanisms can alleviate symptoms in animal models.<\/p>\n
Researchers are now exploring molecules capable of targeting these different cell death pathways. Some, such as natural extracts or specific inhibitors, have already demonstrated their ability to reduce inflammation, protect neurons, and improve cognitive performance in experimental models. These advances suggest that modulating programmed cell death could offer new strategies for preventing or treating Alzheimer’s disease, acting not only on the symptoms but also on the underlying causes of neuronal degeneration.<\/p>\n
DOI:<\/strong> https:\/\/doi.org\/10.1007\/s10495-026-02330-1<\/a><\/p>\n Title:<\/strong> Programmed cell death: a promising management for Alzheimer\u2019s disease<\/p>\n Journal:<\/strong> Apoptosis<\/p>\n Publisher:<\/strong> Springer Science and Business Media LLC<\/p>\n Authors:<\/strong> Qianqian Yang; Xinxin Ren; Ruonan Jia; Ludan Zheng; Renhao Ou; Yana Xu; Ying Luo; Gaoyi Yang; Xiang Wang<\/p>\n","protected":false},"excerpt":{"rendered":" Does Programmed Cell Death Open New Avenues Against Alzheimer’s Disease? Alzheimer’s disease affects an increasing number of elderly individuals and is characterized by a progressive loss of memory, reasoning, and linguistic abilities. Despite the numerous drugs developed, none have yet succeeded in effectively halting or even slowing its progression. However, a promising avenue is emerging:… Continue reading Does Programmed Cell Death Open New Avenues Against Alzheimer’s Disease?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-34","post","type-post","status-publish","format-standard","hentry","category-health","entry"],"_links":{"self":[{"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/posts\/34","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/comments?post=34"}],"version-history":[{"count":1,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/posts\/34\/revisions"}],"predecessor-version":[{"id":35,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/posts\/34\/revisions\/35"}],"wp:attachment":[{"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/media?parent=34"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/categories?post=34"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/en\/wp-json\/wp\/v2\/tags?post=34"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}